AB AllianceBernstein | Reiterated by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.90 +0.4% | $38.00 | Buy | |
ACN Accenture | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $340.27 +0.3% | $376.00 ➝ $370.00 | Overweight ➝ Overweight | |
AHR American Healthcare REIT | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.30 +1.0% | $27.00 ➝ $31.00 | Buy ➝ Buy | |
AIOT Powerfleet | Reiterated by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.91 +2.9% | $10.00 ➝ $10.00 | Outperform ➝ Outperform | |
AIR AAR | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.99 -4.5% | $83.00 ➝ $83.00 | Buy ➝ Buy | |
AIR AAR | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.99 -4.5% | $85.00 ➝ $85.00 | Outperform ➝ Outperform | |
The Fed’s New Rate Cut—The Calm Before the Storm? (Ad) Former hedge fund manager: "Move your money before the Fed's next meeting on July 31"
In 2022, the Federal Reserve raised interest rates and triggered a stock market event that slashed the average investor's portfolio nearly in half. Now, according to the man whom CNBC calls 'The Prophet', the Fed could soon trigger another dramatic stock event – one investors have seen just 13 times since 1920. He warns: "This event will likely dictate the next decade of every American's financial life..." It's critical for you to take steps now to prepare. |
AMWL American Well | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.76 +6.0% | | Hold | |
ANET Arista Networks | Target Raised by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $384.73 -0.2% | $390.00 ➝ $430.00 | Buy ➝ Buy | |
APLS Apellis Pharmaceuticals | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.96 -5.4% | $47.00 ➝ $43.00 | Equal Weight ➝ Equal Weight | |
ASMB Assembly Biosciences | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.32 -5.8% | | Neutral | |
AX Axos Financial | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $64.32 -2.3% | $80.00 ➝ $75.00 | Neutral ➝ Neutral | |
AYI Acuity Brands | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. O'dea Subscribe to MarketBeat All Access for the recommendation accuracy rating | $272.62 +0.3% | $260.00 ➝ $289.00 | Equal Weight ➝ Equal Weight | |
BA Boeing | Target Lowered by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $155.66 -0.4% | $232.00 ➝ $202.00 | Buy ➝ Buy | |
BANC Banc of California | Upgraded by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.99 +1.0% | $14.00 ➝ $18.00 | Neutral ➝ Outperform | |
BDTX Black Diamond Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.59 +2.0% | $11.00 ➝ $11.00 | Buy ➝ Buy | |
BHVN Biohaven | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.02 -2.0% | $59.00 ➝ $59.00 | Buy ➝ Buy | |
BHVN Biohaven | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.02 -2.0% | | Overweight | |
BHVN Biohaven | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.02 -2.0% | $59.00 ➝ $68.00 | Outperform ➝ Outperform | |
BHVN Biohaven | Target Raised by | Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating | W. Pickering Subscribe to MarketBeat All Access for the recommendation accuracy rating | $45.02 -2.0% | $55.00 ➝ $66.00 | Outperform ➝ Outperform | |
BHVN Biohaven | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.02 -2.0% | $52.00 ➝ $62.00 | Buy ➝ Buy | |
BIDU Baidu | Downgraded by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.50 +7.0% | $100.00 | Buy ➝ Hold | |
BIIB Biogen | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $194.16 -0.8% | $285.00 ➝ $285.00 | Buy ➝ Buy | |
BIRK Birkenstock | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating | $50.34 +2.4% | $70.00 ➝ $70.00 | Outperform ➝ Outperform | |
BKU BankUnited | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.27 -0.3% | $39.00 ➝ $40.00 | Neutral ➝ Neutral | |
BNTX BioNTech | Upgraded by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $118.09 +4.5% | $93.00 ➝ $145.00 | Equal Weight ➝ Overweight | |
BP BP | Downgraded by | Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.83 -0.1% | | Buy ➝ Neutral | |
BRO Brown & Brown | Initiated by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $103.13 +0.9% | $120.00 | Buy | |
BRZE Braze | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.62 -5.8% | $70.00 ➝ $70.00 | Buy ➝ Buy | |
BRZE Braze | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.62 -5.8% | $52.00 ➝ $45.00 | Buy ➝ Buy | |
BRZE Braze | Target Lowered by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.62 -5.8% | $60.00 ➝ $51.00 | Outperform ➝ Outperform | |
BRZE Braze | Reiterated by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.62 -5.8% | $75.00 ➝ $75.00 | Buy ➝ Buy | |
BRZE Braze | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.62 -5.8% | $68.00 ➝ $68.00 | Market Outperform ➝ Market Outperform | |
BRZE Braze | Target Lowered by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.62 -5.8% | $65.00 ➝ $55.00 | Buy ➝ Buy | |
BTG B2Gold | Target Raised by | CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.31 +2.2% | $3.30 ➝ $3.60 | Neutral ➝ Neutral | |
CAPR Capricor Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.10 +52.4% | $40.00 ➝ $40.00 | Buy ➝ Buy | |
CART Maplebear | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.74 -1.2% | $45.00 ➝ $41.00 | Equal Weight ➝ Equal Weight | |
CART Maplebear | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.74 -1.2% | | Market Perform | |
CART Maplebear | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.74 -1.2% | $41.00 ➝ $45.00 | Neutral ➝ Neutral | |
CAVA CAVA Group | Target Raised by | TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $127.44 -0.6% | $115.00 ➝ $130.00 | Buy ➝ Buy | |
CBUS Cibus | Target Lowered by | Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Venezia Subscribe to MarketBeat All Access for the recommendation accuracy rating | $3.80 +6.7% | $25.00 ➝ $23.50 | Buy ➝ Buy | |
The Fed’s New Rate Cut—The Calm Before the Storm? (Ad) Former hedge fund manager: "Move your money before the Fed's next meeting on July 31"
In 2022, the Federal Reserve raised interest rates and triggered a stock market event that slashed the average investor's portfolio nearly in half. Now, according to the man whom CNBC calls 'The Prophet', the Fed could soon trigger another dramatic stock event – one investors have seen just 13 times since 1920. He warns: "This event will likely dictate the next decade of every American's financial life..." It's critical for you to take steps now to prepare. |
CCK Crown | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $95.72 +0.3% | $105.00 ➝ $105.00 | Outperform ➝ Outperform | |
CELH Celsius | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.75 -3.2% | $50.00 ➝ $47.00 | Overweight ➝ Overweight | |
CF CF Industries | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $85.06 +2.1% | $88.00 ➝ $92.00 | Overweight ➝ Overweight | |
CFLT Confluent | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.81 +0.6% | $40.00 ➝ $40.00 | Market Outperform ➝ Market Outperform | |
CFR Cullen/Frost Bankers | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $112.38 -0.1% | $124.00 ➝ $123.00 | Neutral ➝ Neutral | |
CHD Church & Dwight | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $103.14 -0.4% | $120.00 | Overweight | |
CHKP Check Point Software Technologies | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $195.13 -0.2% | $210.00 ➝ $225.00 | Buy ➝ Buy | |
CL Colgate-Palmolive | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $103.71 +0.4% | $121.00 | Overweight | |
CLFD Clearfield | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.46 +1.8% | $50.00 ➝ $50.00 | Buy ➝ Buy | |
CMA Comerica | Upgraded by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $60.41 +0.3% | $52.00 ➝ $75.00 | Neutral ➝ Outperform | |
COGT Cogent Biosciences | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.95 +2.8% | $13.00 ➝ $15.00 | Buy ➝ Buy | |
COLB Columbia Banking System | Upgraded by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.16 +1.6% | $28.00 ➝ $31.00 | Neutral ➝ Outperform | |
COMP Compass | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.59 +6.3% | $6.00 ➝ $8.00 | Outperform ➝ Outperform | |
COST Costco Wholesale | Downgraded by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $901.54 -1.7% | $873.00 ➝ $873.00 | Buy ➝ Hold | |
CRGY Crescent Energy | Reiterated by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.65 +1.9% | $17.00 | Outperform | |
CRM Salesforce | Upgraded by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $270.30 +2.3% | $268.00 ➝ $325.00 | Neutral ➝ Overweight | |
CRWD CrowdStrike | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $288.42 -1.6% | $315.00 ➝ $345.00 | Buy ➝ Buy | |
CRWD CrowdStrike | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $288.42 -1.6% | $400.00 ➝ $400.00 | Market Outperform ➝ Market Outperform | |
CTLT Catalent | Reiterated by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $60.14 +0.7% | $63.50 ➝ $63.50 | Outperform ➝ Neutral | |
CTVA Corteva | Reiterated by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.85 -0.3% | $65.00 ➝ $65.00 | Overweight ➝ Overweight | |
CUBI Customers Bancorp | Downgraded by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.83 -2.5% | $79.00 ➝ $53.00 | Outperform ➝ Neutral | |
CVBF CVB Financial | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.83 -1.7% | $21.00 ➝ $20.00 | Neutral ➝ Neutral | |
CYBR CyberArk Software | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $284.55 +0.1% | $315.00 ➝ $330.00 | Buy ➝ Buy | |
DASH DoorDash | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $141.25 +1.2% | $155.00 | Outperform | |
DAY Dayforce | Initiated by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $60.41 +2.0% | $70.00 | Overweight | |
DBVT DBV Technologies | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.73 +4.3% | $5.00 ➝ $5.00 | Market Outperform ➝ Market Outperform | |
DOYU DouYu International | Downgraded by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.43 +1.5% | | Hold ➝ Reduce | |
DRS Leonardo DRS | Downgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.06 -5.3% | $26.00 ➝ $30.00 | Buy ➝ Neutral | |
EBAY eBay | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.44 +3.1% | $57.00 ➝ $65.00 | Neutral ➝ Neutral | |
EC Ecopetrol | Target Lowered by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.32 +0.6% | $11.00 ➝ $9.50 | Neutral ➝ Neutral | |
EH EHang | Initiated by | China Renaissance Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.24 +12.5% | | Buy | |
EL Estée Lauder Companies | Reiterated by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.98 +6.1% | $130.00 ➝ $130.00 | Buy ➝ Buy | |
ENGN enGene | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.20 -3.3% | $30.00 ➝ $30.00 | Outperform ➝ Outperform | |
EPR EPR Properties | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.69 +0.6% | | Market Perform | |
EQIX Equinix | Reiterated by | Cfra Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $887.58 +0.6% | | Buy ➝ Hold | |
EQR Equity Residential | Downgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.28 -1.9% | $78.00 ➝ $82.00 | Buy ➝ Neutral | |
ESS Essex Property Trust | Downgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $300.68 -2.9% | $307.00 ➝ $321.00 | Buy ➝ Neutral | |
ETSY Etsy | Reiterated by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.01 +0.3% | $76.00 ➝ $76.00 | Buy ➝ Buy | |
FBLG FibroBiologics | Initiated by | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.92 +5.8% | $12.00 | Buy | |
FCNCA First Citizens BancShares | Downgraded by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,861.60 -4.8% | $2,450.00 ➝ $2,150.00 | Outperform ➝ Neutral | |
FFIV F5 | Target Raised by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $223.60 +1.5% | $185.00 ➝ $212.00 | Neutral ➝ Neutral | |
FHN First Horizon | Downgraded by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.30 -2.4% | $20.00 ➝ $17.00 | Outperform ➝ Neutral | |
FHTX Foghorn Therapeutics | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.56 +2.6% | $6.00 ➝ $9.00 | Equal Weight ➝ Equal Weight | |
FLS Flowserve | Reiterated by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.10 +7.2% | $60.00 ➝ $60.00 | Buy ➝ Buy | |
FOXA FOX | Target Raised by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.32 +2.9% | $44.00 ➝ $45.00 | Buy ➝ Buy | |
GEV GE Vernova | Initiated by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $255.48 +1.6% | $300.00 | Buy | |
GNRC Generac | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $150.84 +3.1% | $175.00 ➝ $175.00 | Overweight ➝ Overweight | |
HAFC Hanmi Financial | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.94 -1.3% | $22.00 ➝ $21.00 | Neutral ➝ Neutral | |
HD Home Depot | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $400.66 +2.2% | $345.00 ➝ $400.00 | Market Perform ➝ Market Perform | |
HE Hawaiian Electric Industries | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.81 -10.0% | $16.00 ➝ $9.00 | In-Line ➝ In-Line | |
The Fed’s New Rate Cut—The Calm Before the Storm? (Ad) Former hedge fund manager: "Move your money before the Fed's next meeting on July 31"
In 2022, the Federal Reserve raised interest rates and triggered a stock market event that slashed the average investor's portfolio nearly in half. Now, according to the man whom CNBC calls 'The Prophet', the Fed could soon trigger another dramatic stock event – one investors have seen just 13 times since 1920. He warns: "This event will likely dictate the next decade of every American's financial life..." It's critical for you to take steps now to prepare. |
HRMY Harmony Biosciences | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.16 -0.2% | $52.00 ➝ $52.00 | Buy ➝ Buy | |
HSY Hershey | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $193.48 -0.9% | $204.00 ➝ $202.00 | Equal Weight ➝ Equal Weight | |
HUT Hut 8 | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.52 +8.2% | $15.00 ➝ $16.50 | Buy ➝ Buy | |
IDYA IDEAYA Biosciences | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.32 -7.1% | $61.00 ➝ $61.00 | Outperform ➝ Outperform | |
IDYA IDEAYA Biosciences | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.32 -7.1% | $54.00 ➝ $52.00 | Outperform ➝ Outperform | |
INVH Invitation Homes | Downgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.65 -2.3% | $39.00 ➝ $37.00 | Buy ➝ Neutral | |
JAMF Jamf | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.54 -6.2% | $30.00 ➝ $30.00 | Market Outperform ➝ Market Outperform | |
JAMF Jamf | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.54 -6.2% | $25.00 ➝ $25.00 | Buy ➝ Buy | |
JBHT J.B. Hunt Transport Services | Reiterated by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.48 +2.5% | $195.00 ➝ $195.00 | Outperform ➝ Outperform | |
KEY KeyCorp | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.62 -1.1% | $17.00 ➝ $18.00 | Neutral ➝ Neutral | |
KOD Kodiak Sciences | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Caufield Subscribe to MarketBeat All Access for the recommendation accuracy rating | $2.60 +3.6% | $3.00 ➝ $3.00 | Neutral ➝ Neutral | |
KVUE Kenvue | Downgraded by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.11 +0.4% | $24.00 | Outperform ➝ Sector Perform | |
KVUE Kenvue | Initiated by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.11 +0.4% | $27.00 | Buy | |
LH Laboratory Co. of America | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $220.85 -1.7% | $250.00 ➝ $240.00 | In-Line ➝ In-Line | |
LI Li Auto | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Chung Subscribe to MarketBeat All Access for the recommendation accuracy rating | $24.67 +11.1% | $21.60 ➝ $25.50 | Neutral ➝ Neutral | |
LNW Light & Wonder | Target Lowered by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Stauff Subscribe to MarketBeat All Access for the recommendation accuracy rating | $90.67 -19.5% | $92.00 ➝ $90.00 | Neutral ➝ Neutral | |
LOW Lowe's Companies | Upgraded by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $266.04 +1.4% | $230.00 ➝ $305.00 | Market Perform ➝ Outperform | |
LPCN Lipocine | Initiated by | Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.50 -0.9% | $10.00 | Buy | |
LW Lamb Weston | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Moskow Subscribe to MarketBeat All Access for the recommendation accuracy rating | $65.01 +0.2% | $61.00 ➝ $65.00 | Hold ➝ Hold | |
LWAY Lifeway Foods | Downgraded by | Noble Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Gomes Subscribe to MarketBeat All Access for the recommendation accuracy rating | $26.57 +23.6% | | Outperform ➝ Market Perform | |
LYFT Lyft | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.32 +4.7% | | Market Perform | |
MCD McDonald's | Target Raised by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Cho Subscribe to MarketBeat All Access for the recommendation accuracy rating | $300.27 +0.4% | $284.00 ➝ $325.00 | Neutral ➝ Neutral | |
MCK McKesson | Reiterated by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $480.49 -4.9% | $603.00 ➝ $531.00 | Outperform ➝ Neutral | |
MESO Mesoblast | Upgraded by | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.23 +7.3% | $12.00 | Hold ➝ Buy | |
MOD Modine Manufacturing | Target Raised by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $133.97 +5.4% | $140.00 ➝ $155.00 | Buy ➝ Buy | |
MOGO Mogo | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.20 +3.7% | $6.00 ➝ $6.00 | Buy ➝ Buy | |
MOS Mosaic | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.60 +1.0% | $29.00 ➝ $27.00 | Equal Weight ➝ Equal Weight | |
MRNS Marinus Pharmaceuticals | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.95 +19.6% | $13.00 ➝ $13.00 | Overweight ➝ Overweight | |
MTB M&T Bank | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.84 -1.6% | $208.00 ➝ $210.00 | Outperform ➝ Outperform | |
NEO NeoGenomics | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.81 +0.1% | $18.00 ➝ $18.00 | Buy ➝ Buy | |
NHI National Health Investors | Initiated by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.01 -0.8% | $92.00 | Buy | |
NSP Insperity | Downgraded by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $86.88 -4.5% | | Outperform ➝ Market Perform | |
NTR Nutrien | Downgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $47.72 +0.5% | $62.00 ➝ $50.00 | Overweight ➝ Equal Weight | |
OKTA Okta | Target Lowered by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.93 -0.3% | $100.00 ➝ $85.00 | Hold ➝ Hold | |
OMF OneMain | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.91 -5.0% | $60.00 ➝ $60.00 | Market Outperform ➝ Market Outperform | |
PB Prosperity Bancshares | Upgraded by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.20 -1.6% | $75.00 ➝ $90.00 | Neutral ➝ Outperform | |
PBH Prestige Consumer Healthcare | Reiterated by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.13 -1.6% | $70.00 ➝ $76.00 | Buy ➝ Hold | |
PCOR Procore Technologies | Initiated by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $61.43 +4.3% | $73.00 | Outperform | |
PCRX Pacira BioSciences | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.23 -0.4% | $15.00 ➝ $18.00 | Buy ➝ Buy | |
PEG Public Service Enterprise Group | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $87.64 -0.3% | $87.00 ➝ $94.00 | Neutral ➝ Neutral | |
PG Procter & Gamble | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $173.24 -0.3% | $174.00 | Neutral | |
PINS Pinterest | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.82 +4.5% | $45.00 | Outperform | |
PPBI Pacific Premier Bancorp | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.25 -0.6% | $28.00 ➝ $27.00 | Neutral ➝ Neutral | |
PTGX Protagonist Therapeutics | Initiated by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $46.58 +0.9% | $65.00 | Buy | |
QUAD Quad/Graphics | Reiterated by | Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Crockett Subscribe to MarketBeat All Access for the recommendation accuracy rating | $4.71 -2.9% | $7.60 ➝ $7.60 | Buy ➝ Buy | |
REGN Regeneron Pharmaceuticals | Reiterated by | Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,044.05 -4.4% | $1,175.00 ➝ $1,077.00 | Outperform ➝ Market Perform | |
REGN Regeneron Pharmaceuticals | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,044.05 -4.4% | $1,282.00 ➝ $1,252.00 | Outperform ➝ Outperform | |
REGN Regeneron Pharmaceuticals | Reiterated by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,044.05 -4.4% | $1,300.00 ➝ $1,300.00 | Outperform ➝ Outperform | |
REGN Regeneron Pharmaceuticals | Reiterated by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,044.05 -4.4% | $1,200.00 ➝ $1,200.00 | Buy ➝ Buy | |
REPL Replimune Group | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.07 +1.0% | $14.00 ➝ $17.00 | Overweight ➝ Overweight | |
Trump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absolute (Ad) Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs).
If these plans are implemented, it could mean the end of America as we know it. This means you must act NOW before it's too late. |
RF Regions Financial | Upgraded by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.92 +0.0% | $23.00 ➝ $28.00 | Neutral ➝ Outperform | |
RGA Reinsurance Group of America | Target Raised by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $219.50 -0.3% | $228.00 ➝ $250.00 | Strong-Buy ➝ Strong-Buy | |
RMD ResMed | Initiated by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $247.13 +0.4% | $280.00 | Outperform | |
RNA Avidity Biosciences | Initiated by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.00 +1.1% | $59.00 | Buy | |
RUN Sunrun | Reiterated by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.91
| $35.00 ➝ $35.00 | Overweight ➝ Overweight | |
RYAN Ryan Specialty | Upgraded by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $67.39 +5.1% | $65.00 ➝ $75.00 | Market Perform ➝ Outperform | |
SBUX Starbucks | Downgraded by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.53 -1.0% | $80.00 ➝ $76.00 | Hold ➝ Underperform | |
SHAK Shake Shack | Reiterated by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.43 -2.0% | $105.00 ➝ $102.00 | Underweight ➝ Underweight | |
SIRI Sirius XM | Reiterated by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.20 -5.4% | $23.00 | Underweight | |
SLM SLM | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.50 -2.6% | $29.00 ➝ $26.00 | Outperform ➝ Outperform | |
SNOW Snowflake | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $112.04 -1.1% | $155.00 ➝ $125.00 | Neutral ➝ Neutral | |
SOC Sable Offshore | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Chandra Subscribe to MarketBeat All Access for the recommendation accuracy rating | $24.82 +6.2% | $24.00 ➝ $37.00 | Buy ➝ Buy | |
STZ Constellation Brands | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $252.32 -1.0% | $295.00 ➝ $309.00 | Overweight ➝ Overweight | |
TBLA Taboola.com | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.20 +0.3% | $5.00 ➝ $5.00 | Buy ➝ Buy | |
TCBI Texas Capital Bancshares | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $70.99 -1.0% | $70.00 ➝ $77.00 | Neutral ➝ Neutral | |
TGI Triumph Group | Downgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.94 -4.5% | $17.00 ➝ $12.00 | Buy ➝ Underperform | |
TMDX TransMedics Group | Initiated by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $156.00 -2.2% | $200.00 | Outperform | |
TRIP Tripadvisor | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.90 +2.2% | $20.00 ➝ $16.00 | Neutral ➝ Neutral | |
TXRH Texas Roadhouse | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $175.58 +0.2% | $190.00 ➝ $190.00 | Outperform ➝ Outperform | |
UBER Uber Technologies | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.44 +3.7% | $90.00 | Strong-Buy | |
UNP Union Pacific | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $248.37 +1.8% | $273.00 ➝ $270.00 | Buy ➝ Buy | |
V Visa | Reiterated by | Monness Crespi & Hardt Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $272.78 -5.5% | | Neutral | |
VAL Valaris | Initiated by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $56.92 +2.7% | $62.00 | Neutral | |
VLY Valley National Bancorp | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.84 -2.2% | $9.00 ➝ $10.00 | Neutral ➝ Neutral | |
VST Vistra | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $112.40 +0.7% | $99.00 ➝ $137.00 | Buy ➝ Buy | |
VZ Verizon Communications | Target Raised by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.60 +0.8% | $44.00 ➝ $48.00 | Outperform ➝ Outperform | |
WAL Western Alliance Bancorporation | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $85.05 -1.5% | $90.00 ➝ $105.00 | Outperform ➝ Outperform | |
WMT Walmart | Upgraded by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $80.67 +0.4% | $76.00 ➝ $89.00 | Hold ➝ Buy | |
XOM Exxon Mobil | Reiterated by | Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.11 -0.2% | $119.00 ➝ $120.00 | Buy ➝ Neutral | |
ZVRA Zevra Therapeutics | Target Raised by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.32 +9.8% | $19.00 ➝ $21.00 | Buy ➝ Buy | |
ZVRA Zevra Therapeutics | Initiated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.32 +9.8% | $17.00 | Outperform | |
ZVRA Zevra Therapeutics | Target Raised by | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.32 +9.8% | $18.00 ➝ $25.00 | Buy ➝ Buy | |